Search research articles
Contact Us
Filters
Showing results (71-80 of 216) with videos related to
Page
of 22
Sort By:
Brain : a Journal of Neurology
|
September 26, 2001
In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion
A Cagnin, R Myers, R N Gunn, et al.
NMR in Biomedicine
|
November 29, 2021
Kinetic modelling of dissolution dynamic nuclear polarisation <sup>13</sup> C magnetic resonance spectroscopy data for analysis of pyruvate delivery and fate in tumours
Steven Reynolds, Samira M Kazan, Adriana Anton, et al.
Neurology
|
November 4, 2000
Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195
S Pappata, M Levasseur, R N Gunn, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
February 7, 2013
Kinetic analysis of drug-target interactions with PET for characterization of pharmacological hysteresis
Cristian Salinas, David Weinzimmer, Graham Searle, et al.
Lancet (London, England)
|
August 22, 2001
In-vivo measurement of activated microglia in dementia
A Cagnin, D J Brooks, A M Kennedy, et al.
Neuropharmacology
|
January 1, 1996
Benzodiazepine site pharmacokinetic/pharmacodynamic quantification in man: direct measurement of drug occupancy and effects on the human brain in vivo
A L Malizia, R N Gunn, S J Wilson, et al.
European Journal of Nuclear Medicine
|
December 1, 1996
Non-invasive measurement of left ventricular volumes and function by gated positron emission tomography
H L Boyd, R N Gunn, N V Marinho, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 23, 2002
5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: a[11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635) positron emission tomography study in humans
Eugenii A Rabiner, Martin R Wilkins, Federico Turkheimer, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
May 17, 2021
Reproducibility of findings in modern PET neuroimaging: insight from the NRM2018 grand challenge
Mattia Veronese, Gaia Rizzo, Martin Belzunce, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1996
Uptake of [N-methyl-11C]propionyl-L-carnitine (PLC) in human myocardium
V J Cunningham, S D Rosen, H Boyd, et al.
Page
of 22
Search research articles
Search
Showing results (71-80 of 216) with videos related to
Sort By:
Page
of 22
Brain : a Journal of Neurology
|
September 26, 2001
In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion
A Cagnin, R Myers, R N Gunn, et al.
NMR in Biomedicine
|
November 29, 2021
Kinetic modelling of dissolution dynamic nuclear polarisation <sup>13</sup> C magnetic resonance spectroscopy data for analysis of pyruvate delivery and fate in tumours
Steven Reynolds, Samira M Kazan, Adriana Anton, et al.
Neurology
|
November 4, 2000
Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195
S Pappata, M Levasseur, R N Gunn, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
February 7, 2013
Kinetic analysis of drug-target interactions with PET for characterization of pharmacological hysteresis
Cristian Salinas, David Weinzimmer, Graham Searle, et al.
Lancet (London, England)
|
August 22, 2001
In-vivo measurement of activated microglia in dementia
A Cagnin, D J Brooks, A M Kennedy, et al.
Neuropharmacology
|
January 1, 1996
Benzodiazepine site pharmacokinetic/pharmacodynamic quantification in man: direct measurement of drug occupancy and effects on the human brain in vivo
A L Malizia, R N Gunn, S J Wilson, et al.
European Journal of Nuclear Medicine
|
December 1, 1996
Non-invasive measurement of left ventricular volumes and function by gated positron emission tomography
H L Boyd, R N Gunn, N V Marinho, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 23, 2002
5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: a[11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635) positron emission tomography study in humans
Eugenii A Rabiner, Martin R Wilkins, Federico Turkheimer, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
May 17, 2021
Reproducibility of findings in modern PET neuroimaging: insight from the NRM2018 grand challenge
Mattia Veronese, Gaia Rizzo, Martin Belzunce, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1996
Uptake of [N-methyl-11C]propionyl-L-carnitine (PLC) in human myocardium
V J Cunningham, S D Rosen, H Boyd, et al.
Page
of 22